C-myc Contributes to Malignancy of Lung Cancer: A Potential Anticancer Drug Target.
Anticancer Res. 2020 Feb;40(2):609-618. doi: 10.21873/anticanres.13990.
Anticancer Res. 2020.
PMID: 32014901
Review.